25 results
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
Topical drug formulations ... #pharmacology #table ... #medications #comparison ... #drugs #treatment ... #pharmacotherapy
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
#antibiotics #medications ... #table #treatment ... #drugs #pharmacotherapy
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... #pharmacology #treatment ... #medications #table ... #pharmacotherapy ... decisionaid #cardiology #hematology
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
are usually the drugs ... pharmacology #comparison #treatment ... #medications #dosing ... #drugs #table # ... pharmacotherapy
Hyponatremia - Differential Diagnosis by Mechanism
Decr Blood Pressure (“Decr Effective Circulating Volume”) 
 - Volume depletion
- Differential Diagnosis ... the lung) - CNS ... hemorrhage) - Pulmonary ... exacerbation) - Drugs ... #Table #Causes
Approach to Eosinophilic Lung Diseases
 • Acute Eosinophilic Pneumonia (< 1 wk) - ~30yo, M; Recent
, wt loss; CV, CNS ... Fever, wheezing • Drug ... Lung #Diseases #pulmonary ... #differential #diagnosis ... #comparison #table
Eosinophil Disorders Testing Algorithm
INDICATIONS FOR TESTING:
 • Peripheral blood eosinophilia/hypereosinophilia uncovered incidentally during medical evaluation or
Testing Algorithm INDICATIONS ... asthma, allergy, drug ... glucocorticoid treatment ... #Differential #diagnosis ... #hematology #eosinophilia
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
constitutional symptoms • Treatment ... life-threatening • Treatment ... sle #comparison #table ... #rheumatology # ... diagnosis #management
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
: 33% • Treatment ... , and CXR with pulmonary ... : No • Treatment ... #diagnosis #comparison ... #table
Mycoses

HISTOPLASMOSIS
• Inhalation of conidia → Yeast → travel to lymph nodes → spread in body
• Bird
host): • Chronic pulmonary ... symptoms • Rheumatologic ... Histoplasmosis Diagnosis ... especially the CNS ... MC: CNS CSF: •